Literature DB >> 17347479

Intimal smooth muscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro.

Anne C Brisset1, Hiroyuki Hao, Edoardo Camenzind, Marc Bacchetta, Antoine Geinoz, Jean-Charles Sanchez, Christine Chaponnier, Giulio Gabbiani, Marie-Luce Bochaton-Piallat.   

Abstract

We reported that smooth muscle cell (SMC) populations isolated from normal porcine coronary artery media exhibit distinct phenotypes: spindle-shaped (S) and rhomboid (R). R-SMCs are recovered in higher proportion from stent-induced intimal thickening compared with media suggesting that they participate in intimal thickening formation. Our aim was to identify a marker of R-SMCs in vitro and to explore its possible expression in vivo. S- and R-SMC protein extracts were compared by means of 2-dimensional polyacrylamide gel electrophoresis followed by tandem mass spectrometry. S100A4 was found to be predominantly expressed in R-SMC extracts. Using a monoclonal S100A4 antibody we confirmed that S100A4 is highly expressed by R-SMCs and hardly detectable in S-SMCs. S100A4 was colocalized with alpha-smooth muscle actin in stress fibers of several quiescent cells and upregulated during migration. PDGF-BB, FGF-2 or coculture with endothelial cells, which modulate S-SMCs to a R-phenotype, increased S100A4 expression in both S- and R-SMCs. Silencing of S100A4 mRNA in R-SMCs decreased cell proliferation, suggesting a functional role for this protein. In vivo S100A4 was absent in normal porcine coronary artery media, but highly expressed by SMCs of stent-induced intimal thickening. In humans, S100A4 was barely detectable in coronary artery media and markedly expressed in SMCs of atheromatous and restenotic coronary artery lesions. Our results indicate that S100A4 is a marker of porcine R-SMCs in vitro and of intimal SMCs during intimal thickening development. It is also a marker of a large population of human atheromatous and restenotic SMCs. Clarifying S100A4 function might be useful to understand the evolution of atherosclerotic and restenotic processes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17347479     DOI: 10.1161/01.RES.0000262654.84810.6c

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  37 in total

1.  Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis.

Authors:  Ping Kong; Panagiota Christia; Amit Saxena; Ya Su; Nikolaos G Frangogiannis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-30       Impact factor: 4.733

2.  TGFβ2 differentially modulates smooth muscle cell proliferation and migration in electrospun gelatin-fibrinogen constructs.

Authors:  Diana C Ardila; Ehab Tamimi; Forest L Danford; Darren G Haskett; Robert S Kellar; Tom Doetschman; Jonathan P Vande Geest
Journal:  Biomaterials       Date:  2014-10-22       Impact factor: 12.479

3.  TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections.

Authors:  Sakiko Inamoto; Callie S Kwartler; Andrea L Lafont; Yao Yun Liang; Van Tran Fadulu; Senthil Duraisamy; Marcia Willing; Anthony Estrera; Hazim Safi; Mark C Hannibal; John Carey; John Wiktorowicz; Filemon K Tan; Xin-Hua Feng; Hariyadarshi Pannu; Dianna M Milewicz
Journal:  Cardiovasc Res       Date:  2010-07-13       Impact factor: 10.787

4.  Fibroblasts: Diverse Cells Critical to Biomaterials Integration.

Authors:  Riley T Hannan; Shayn M Peirce; Thomas H Barker
Journal:  ACS Biomater Sci Eng       Date:  2017-06-13

5.  Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury.

Authors:  David P Basile; Jessica L Friedrich; Jasmina Spahic; Nicole Knipe; Henry Mang; Ellen C Leonard; Saeed Changizi-Ashtiyani; Robert L Bacallao; Bruce A Molitoris; Timothy A Sutton
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-01

6.  A gel-free approach in vascular smooth muscle cell proteome: perspectives for a better insight into activation.

Authors:  Silvia Rocchiccioli; Lorenzo Citti; Claudia Boccardi; Nadia Ucciferri; Lorena Tedeschi; Caterina Lande; Maria Giovanna Trivella; Antonella Cecchettini
Journal:  Proteome Sci       Date:  2010-03-24       Impact factor: 2.480

7.  S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4.

Authors:  Edda Spiekerkoetter; Christophe Guignabert; Vinicio de Jesus Perez; Tero-Pekka Alastalo; Janine M Powers; Lingli Wang; Allan Lawrie; Noona Ambartsumian; Ann-Marie Schmidt; Mark Berryman; Richard H Ashley; Marlene Rabinovitch
Journal:  Circ Res       Date:  2009-08-27       Impact factor: 17.367

8.  Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall.

Authors:  Maria G Frid; Min Li; Meena Gnanasekharan; Danielle L Burke; Miguel Fragoso; Derek Strassheim; Joanna L Sylman; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-09-18       Impact factor: 5.464

9.  S100A12 mediates aortic wall remodeling and aortic aneurysm.

Authors:  Marion Hofmann Bowman; Jeannine Wilk; Ahlke Heydemann; Gene Kim; Jalees Rehman; Joseph A Lodato; Jai Raman; Elizabeth M McNally
Journal:  Circ Res       Date:  2009-10-29       Impact factor: 17.367

10.  S100A4 is activated by RhoA and catalyses the polymerization of non-muscle myosin, adhesion complex assembly and contraction in airway smooth muscle.

Authors:  Wenwu Zhang; Susan J Gunst
Journal:  J Physiol       Date:  2020-09-11       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.